Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
A legfontosabb adatok
- Ki végzi
- Ottawa Heart Institute Research Corporation
- Hol
- Calgary, Edmonton, Greater Sudbury, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Saint John, St. John's és Toronto (Kanada)Mind a 14 helyszín megnézéseMég 2 másik országban, 17 helyszínen
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 610 fő, tervezett
- Kezdés
- 2018. szept. 1.
- Várható befejezés
- 2035. máj. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
- A vizsgált kezelések
- Thoracic Aortic Surgery
- A regiszteradat frissítve
- 2026. november 2.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a widened ascending aorta (aneurysm) of 5.0cm (2 in) to 5.4cm (2,1 in). People are randomly put into early surgery or close monitoring.
- Életkor
- 18 to 79 years
- Nem
- All sexes
- A betegség stádiuma
- Ascending aortic aneurysm between 5.0cm (2 in) and 5.4cm (2,1 in) at its widest, measured by CT with contrast. It must cause no symptoms. People with 4.5 cm (1,8 in) - 4.9 cm (1,9 in) are watched with CT scans and can join once it reaches 5.0 cm (2 in).
- Korábbi kezelés
- People who had heart surgery before cannot join.
A részvétel fő kizáró okai
- Known connective tissue disease (such as Marfan, Loey-Dietz or Turner syndrome) or possible inherited aorta disease
- Aneurysm growing faster than 0.5 cm/year during the past 5 years, or involving the descending aorta
- Inflammation of the arteries (such as Takayasu's or syphilitic arteritis)
- Pregnant or planning to become pregnant
- Not fit enough for surgery, for example severe lung disease, NYHA III or IV heart failure, heart attack within 6 months, or expected survival under 5 years
A regiszter feltételei, szó szerint
Mind a 18 feltétel megnézéseKevesebb
Ki vehet részt
- Patients between the age of 18 and 79 inclusive
- Ascending aortic aneurysm between 5.0cm and 5.4cm in maximal diameter as measured by CT with contrast
- Patients with ascending aortic aneurysm with a diameter of 4.5 cm - 4.9 cm will be observed with serial CT, and will be considered for enrollment into the trial once the aneurysm reaches 5.0 cm
Ki nem vehet részt
- Previous cardiac surgery
- Patients whose primary indication for cardiac surgery is non-AsAA related
- Patients with known connective tissue disease (E.g. Marfan syndrome, Loey-Dietz syndrome, Turner syndrome etc) syndrome, etc.)
- Patients with possible genetic aortopathies (eg known family history of aortic aneurysms/premature aortic dissections/ruptures)
- Patients who have a history or presence of a medical condition or disease or psychiatric condition that in the investigator's assessment would render the subject ineligible for study participation
- Patients who, in the opinion of the investigator, are deemed unfit for surgery for reasons that may include:; Severe pulmonary disease; Cr = 250umol/L; Child Pugh Class B or C; NYHA III or IV; MI within the last 6 months; Major surgical procedure or angioplasty within 3 months; Expected survival less than 5 years because of other disease (e.g. invasive cancer)
- Patients who refused to be randomized
- Patients with symptomatic attributable to ascending aortic aneurysms
- Patients who are unable to provide informed consents
- Patients who are unable to attend for regular follow-up/ remain compliant with protocol
- Known AsAA expansion rate exceeding 0.5 cm/year during the past 5 years
- Arch aneurysms with no ascending aorta involvement (no aneurysmal segments before the innominate artery)
- Ascending aortic and arch aneurysm with descending thoracic aorta involvement
- Patients with inflammatory arteritis (e.g. takayasu's arteritis, syphilitic arteritis, etc.)
- Female patients who are pregnant or planning to become pregnant
Nézd meg, megfelelhetsz-e
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 79 év között vagy?
Helyszínek itt: Kanada
Még 2 másik országban, 17 helyszínen
- University Of CalgaryCalgary, KanadaContact: Khatira MehdiyevaNo longer taking part
- Mazankowski Alberta Heart InstituteEdmonton, KanadaContact: Nasim BoroumandRésztvevőt keres
- Health Sciences NorthGreater Sudbury, KanadaContact: Rony Atoui, MD (principal investigator)Résztvevőt keres
- Nova Scotia Health AuthorityHalifax, KanadaContact: Cynthia UkeomaRésztvevőt keres
- Hamilton General HospitalHamilton, KanadaContact: Khatira MehdiyevaNo longer taking part
- London Health Sciences CentreLondon, KanadaContact: Michael Chu, MD (principal investigator)Résztvevőt keres
- McGill University Health CentreMontreal, KanadaContact: Kevin Lachapelle, MD (principal investigator)Résztvevőt keres
- Montreal Heart InstituteMontreal, KanadaContact: Philippe Demers, MDRésztvevőt keres
- University of Ottawa Heart InstituteOttawa, KanadaContact: Munir Boodhwani, MDRésztvevőt keres
- Institut universitaire de cardiologie et de pneumologie de QuébecQuébec, KanadaContact: François Dagenais, MD (principal investigator)Résztvevőt keres
- Horizon Health NetworkSaint John, KanadaContact: Zlatko Pozeg, MD (principal investigator)Résztvevőt keres
- Newfoundland Health ServicesSt. John's, KanadaContact: Shianne BesonRésztvevőt keres
- St. Michael's HospitalToronto, KanadaContact: Mark Peterson, MD (principal investigator)Toborzás még nem indult
- Toronto General HospitalToronto, KanadaContact: Maral Ouzounian, MD (principal investigator)Résztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The ascending aorta conducts blood from the heart to the rest of the body. The ascending aorta can become enlarged, and the risk of tearing and rupturing becomes higher with larger aorta. When the ascending aorta tears or ruptures, the risk dying is high even if surgery is done as soon as possible. Traditionally, when the ascending aorta gets above 5.5 cm, surgery is recommended to replace the aorta. However, this threshold is based relatively weak evidence, and sometimes patients with smaller aorta can tear or rupture. On the other hand, surgery carries its own risk as well. Since there are risk of waiting or doing surgery, there is currently no great support for either approach for patients with a smaller aorta. In the TITAN SvS trial, patients with an ascending aorta between 5.0 to 5.5 cm is assigned by chance to the early surgery group, in which they will undergo replacement of aorta, or the surveillance group, in which they will be closely monitored. The chance of dying or suffer tearing or rupture of aorta between the two groups will be compared. The result of the trial will guide future practice for patients with enlarged ascending aorta.
A teljes eredeti leírásKevesebb
This is a prospective, multi-centre randomized control trial that compares the all-cause mortality, aneurysm-related aortic events, rate of stroke, and quality of life for those patients undergoing early elective ascending aortic surgery to those patients undergoing surveillance. Patients referred for an ascending aortic aneurysm that meets the inclusion criteria will be randomized to the early elective surgery group or the surveillance group. Recruitment will end when the desired sample size is reached, and the patients will be followed for a minimum 2-year period. The primary objective of the trial is to compare the composite outcome of the all-cause mortality and incidence of acute aortic events between surveillance and elective ascending aortic surgery for patients with degenerative or bicuspid valve-related ascending aortic aneurysm after 2 years of follow up. The hypothesis is that the early surgery group will have a significantly lower all-cause mortality and incidence of acute aortic events at 2 years of follow up compare to the surveillance group. The result of this trial will provide evidence based guidance in the appropriate management of ascending aortic aneurysm based on the size criteria, and establish a large database for future investigations.
A vizsgálat 2 csoportja
- Surveillance ArmNincs vizsgálati kezelés, összehasonlításként
Patients in the Non-Operative Registry will be followed in clinic annually with a CT scan to monitor the status of their ascending aortic aneurysm, until the end of the study, the occurrence of an aortic event, or death.
- Surgery/Treatment ArmEgyéb csoport
Patients in the Operative Registry will have thoracic aortic surgery
Kezelés: Thoracic Aortic Surgery
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance (TITAN:SvS)
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Illeszkedési kérdések
- Forrás: NCT03536312: ki vehet részt
- Publikációk
- Impact of nondiameter aortic indices on surgical eligibility: Results from the Treatment in Thoracic Aortic Aneurysm: Surgery Versus Surveillance (TITAN: SvS) randomized controlled trial.The Journal of thoracic and cardiovascular surgery, 2025
- Protocol for a randomised controlled trial for Treatment in Thoracic Aortic Aneurysm: Surgery versus Surveillance (TITAN: SvS).BMJ open, 2021
- A regiszteradat frissítve
- 2026. november 2.